HRR - Gap - MICRO-01: We need to determine the efficacy of current countermeasures and the need for countermeasure development based on changes in microbial populations and characteristics. (Previous title: AEH 10)

NASA Logo Human Research Roadmap HRP Exploration Data

Evidence Risks Gaps Tasks Reports

Explore Search

MICRO-01: We need to determine the efficacy of current countermeasures and the need for countermeasure development based on changes in microbial populations and characteristics. (Previous title: AEH 10)

This Gap was split into the following Gaps:

Micro-202: Evaluate the contribution of changes in microbial numbers, types, and virulence on the likelihood and consequence of non-infection-based effects on health and performance, including: decrease in cognition/mood/performance/blood-brain barrier (BBB) function related to the change in the gut’s microbiome and gut-brain axis, increase in cardiovascular health risks, effects of change in gut microbiome on metabolism of nutrients, and correlation with inflammation.

Micro-401: Test, optimize and validate existing terrestrial or novel technologies that can maintain in-flight microbial counts, types, and virulence at terrestrial equivalent levels.

Split Rationale

No rationale available.

NASA Developer: Daniel Febus Responsible NASA Official: Susan Torney Contact HRP for a 508 compliant PDF Budgets, Strategic Plans, and Accountability Reports Equal Employment Opportunity Data Posted Pursuant to the No Fear Act Information-Dissemination Policies and Inventories Freedom of Information Act President's Management Agenda Privacy Policy & Important Notices Inspector General Hotline Contact HRP Human Health and Performance DIR Johnson Space Center USA.gov ExpectMore.gov